Global Immunoassay Market 2022 - Industry Briefing

May 2022 | 44 pages | ID: G1CF648FA28EEN
Gen Consulting Company

Abstracts

An immunoassay is a test that relies on biochemistry to measure the presence and/or concentration of an analyte. The analyte can be large proteins, antibodies that a person has produced as a result of an infection or small molecules. The global immunoassay market is likely to register a CAGR of over 6.1% with an incremental growth of USD 9 billion during the forecast period 2022-2028.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market data on immunoassay can be segmented by product: reagent & kits, analyzers, software & services. In 2021, the reagent & kits segment made up the largest share of revenue generated by the immunoassay market. Immunoassay market is further segmented by technology: chemiluminescence immunoassays (CLIA), fluorescence immunoassays (FIA), radioimmunoassay (RIA), rapid test, others. Based on application, the immunoassay market is segmented into: autoimmune disease, cardiology, endocrinology, infectious disease testing, oncology, therapeutic drug monitoring, others. On the basis of end user, the immunoassay market also can be divided into: academia, blood banks, clinical laboratories, hospitals, pharmaceutical & biotech companies, others. Immunoassay market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

The global immunoassay market is highly competitive. The key players in the immunoassay market include Abbott Laboratories, Becton Dickinson and Company, bioMerieux Inc., Bio-Rad Laboratories Inc., Danaher Corporation (Beckman Coulter Inc.), DiaSorin S.p.A., F. Hoffmann-La Roche AG, Meril Life Sciences Pvt. Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Randox Laboratories Ltd., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Immunoassay Market
• Identify segments/areas to invest in over the forecast period in the Global Immunoassay Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

Part 1. Summary
Part 2. Introduction
Study period
Geographical scope
Market segmentation
Part 3. Immunoassay market overview
Part 4. Market breakdown by product
Reagent & kits
Analyzers
Software & services
Part 5. Market breakdown by technology
Chemiluminescence immunoassays (CLIA)
Fluorescence immunoassays (FIA)
Radioimmunoassay (RIA)
Rapid test
Others
Part 6. Market breakdown by application
Autoimmune disease
Cardiology
Endocrinology
Infectious disease testing
Oncology
Therapeutic drug monitoring
Others
Part 7. Market breakdown by end user
Academia
Blood banks
Clinical laboratories
Hospitals
Pharmaceutical & biotech companies
Others
Part 8. Market breakdown by region
Asia Pacific
Europe
North America
Rest of the World (RoW)
Part 9. Key companies
Abbott Laboratories
Becton, Dickinson and Company
bioMerieux, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter Inc.)
DiaSorin S.p.A.
F. Hoffmann-La Roche AG
Meril Life Sciences Pvt. Ltd.
Ortho Clinical Diagnostics Holdings plc
Quidel Corporation
Randox Laboratories Ltd.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific, Inc.
Part 10. Methodology